Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00222352
Status:
COMPLETED
Last Update Posted:
2018-02-05
First Post:
2005-09-14
Brief Title:
Diagnosis and Treatment of ACS in the ED The Impact of Rapid Bedside cTnI Testing on Outcomes
Sponsor:
Organization:
University of Cincinnati
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
SERUM BANKING Each patient consented and enrolled will have whole blood and plasma saved and frozen The amount of blood drawn for the study is 5 ml per draw which is to be placed in a lithium heparinzed tube One ml of whole blood will be alloquoted frozen at -70ºC and shipped to the Study Coordinating Center The remainder of the sample will be centrifuged alloquoted frozen at -70ºC and shipped to the Study Coordinating Center These blood samples will be de-identified and assigned a study ID There will be no genetic testing of these samples
Enrollment Count:
2000
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 1433 |
Who Masked List: